1Fleischmann RM,Schechtman J,Bennett R,et al.Anakinra,a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra),in patients with rheumatoid arthritis:a large,international,multicenter, placebo-controlled trial.Arthritis Rheum,2003,48:927-934.
2Nuki G,Bresnihan B,Bear MB,et al. Long-term safety and maintenance of clinical improvement following treatment with anakinra (recombinant human interleukin-1 receptor antagonist) in patients with rheumatoid arthritis:extension phase of a randomized,double
3Cohen S,Hurd E,Cush J,et al.Treatment of rheumatoid arthritis with anakinra,a recombi nant human interleukin-1 receptor antagonist,in combination with methotrexate:results of a twentyfour-week,multicenter,randomized,double-blind,placebo-controlled trial.
4Cohen S, Moreland L, Cush J,et al. Anakinra (recombinant interleukin-1 receptor antagonist):a large,placebo controlled efficacy trial of anakinra in patients with erosive rheumatoid disease.Arthritis Rheum,2001,44(suppl 19):574-578.
5Arend WP,Malyak M,Guthridge CJ,et al.Interleukin-1 receptor antagonist: role in biology.Annu Rev Immunol,1998,16:27-55.
6Fukumoto T,Matsukawa A,Ohkawara S,et al.Administration of neutralizing antibody against IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits. Inflamm Res, 1996,45:479-485.
7Nicklin MJH,Hughes DE,Barton JL,et al.Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene.J Exp Med,2000,191:303-311.
8Bresnihan B,Alvaro GJM,Cobby M,et al.Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.Arthritis Rheum, 1998,41:2196-2204.
9Watt I,Cobby M.Treatment of rheumatoid arthritis patients with interleukin-1 receptor antagonist:radiologic assessment.Semin Arthritis Rheum,2001,30:21-25.
10Cohen SB,Woolley JM,Chan W,et al. Interleukin 1 receptor antagonist anakinra improves functional status in patients with rheumatoid arthritis.J Rheumatol,2003,30:225-231.
同被引文献8
1MenterA,Gottlieb A,Feldman SR,et al,Guidelincs of care for the management of psoriasis and psoriatic arthritis:Section 1.Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics[J].J Am Acad Dermatol,2008 May;58(5):826-50.
2Greaves MW,Weinstein GD.Treatment of psoriasis[J].N Engl J Med.1995 Mar2;332(9):581-8.
3Henseler T.The genetics ofpsoriasis[J].J Am Acad Dermatol,1997.37:S1-11.
5Arend WP,Malyak M,Guthridge CJ,et al Intefleukin-1 receptor antagonist:role in biology[J].Anau Rev Immund,1998;16:27-55.
6Novick D,Kim SH,Fantuzzi G,et al Interleukin-18 binding protein:a novel modulator of the Th1 cytokine response[J],Immunity,1999 Jan;10(1):127-36.
7Wang M,Tan J,Wang Y,et al IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction[J],Proc Nat Acad Sic U S A,2009 Oct 13;106(41):17499-504.
